UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Sheathless capillary electrophoresis-mass spectrometry for anionic metabolic profiling

Electrophoresis, 2016-04, Vol.37 (7-8), p.1007-1014

2016

Volltextzugriff (PDF)

Sheathless capillary electrophoresis-mass spectrometry for anionic metabolic profiling: Liquid Phase Separations

Electrophoresis, 2016-04, Vol.37 (7-8), p.1007-1014

2016

Volltextzugriff (PDF)

Wanted? Standard operating procedures for journals

Addiction (Abingdon, England), 1995-10, Vol.90 (10), p.1313-1315

Lock, Stephen

1995

Volltextzugriff (PDF)

Research ethics – a brief historical review to 1965

Journal of internal medicine, 1995-12, Vol.238 (6), p.513-520

LOCK, STEPHEN

1995

Volltextzugriff (PDF)

Fraud and the editor

Learned publishing, 1996-07, Vol.9 (3), p.133-140

Lock, Stephen

1996

Volltextzugriff (PDF)

Interaction of ultraviolet light, chemicals and cultured mammalian cells: photobiological reactions of halogenated antiseptics, drugs and dyes

International journal of cosmetic science, 1983-04, Vol.5 (2), p.39-49

1983

Volltextzugriff (PDF)

Fraud and Misconduct in Medical Research (Book Review)

Addiction, 1994, Vol.89 (3), p.358-359

1994

Volltextzugriff (PDF)

Stochastic representations of model uncertainties at ECMWF: state of the art and future vision

Quarterly journal of the Royal Meteorological Society, 2017-07, Vol.143 (707), p.2315-2339

2017

Volltextzugriff (PDF)

In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts

Pediatric blood & cancer, 2023-08, Vol.70 (8), p.e30398-n/a

2023

Volltextzugriff (PDF)

Improved recovery of SARS-CoV-2 from wastewater through application of RNA and DNA stabilising agents

Letters in applied microbiology, 2023-06, Vol.76 (6)

2023

Volltextzugriff (PDF)

Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

Pediatric blood & cancer, 2010-07, Vol.55 (1), p.26-34

2010

Volltextzugriff (PDF)

The pediatric preclinical testing program: Description of models and early testing results

Pediatric blood & cancer, 2007-12, Vol.49 (7), p.928-940

2007

Volltextzugriff (PDF)

In vivo activity of the dual SYK/FLT3 inhibitor TAK‐659 against pediatric acute lymphoblastic leukemia xenografts

Pediatric blood & cancer, 2023-09, Vol.70 (9), p.e30503-n/a

2023

Volltextzugriff (PDF)

Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program

Pediatric blood & cancer, 2013-08, Vol.60 (8), p.1325-1332

2013

Volltextzugriff (PDF)

Initiation of convection over the Black Forest mountains during COPS IOP15a

Quarterly journal of the Royal Meteorological Society, 2011-01, Vol.137 (S1), p.176-189

2011

Volltextzugriff (PDF)

Initial testing of VS‐4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program

Pediatric blood & cancer, 2017-04, Vol.64 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

Pediatric Blood & Cancer, 2008-06, Vol.50 (6), p.1190-1197

2008

Volltextzugriff (PDF)

Understanding species distribution in dynamic populations: a new approach using spatio‐temporal point process models

Ecography (Copenhagen), 2019-06, Vol.42 (6), p.1092-1102

2019

Volltextzugriff (PDF)

Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program

Pediatric blood & cancer, 2013-04, Vol.60 (4), p.633-641

2013

Volltextzugriff (PDF)

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

Pediatric blood & cancer, 2012-06, Vol.58 (6), p.916-923

2012

Volltextzugriff (PDF)

Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program

Pediatric blood & cancer, 2010-10, Vol.55 (4), p.668-677

2010

Volltextzugriff (PDF)

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program

Pediatric blood & cancer, 2011-04, Vol.56 (4), p.595-603

2011

Volltextzugriff (PDF)

Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program

Pediatric blood & cancer, 2010-12, Vol.55 (7), p.1329-1337

2010

Volltextzugriff (PDF)

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

Pediatric blood & cancer, 2008-01, Vol.50 (1), p.37-45

2008

Volltextzugriff (PDF)

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

Pediatric blood & cancer, 2014-02, Vol.61 (2), p.245-252

2014

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(78)

Publikationsform

Artikel
(79)
Reviews
(2)

Sprache

Englisch
(81)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(62)
Hematology
(53)
Humans
(53)
Oncology
(53)
Pediatrics
(53)
Animals
(51)
Developmental Therapeutics
(51)
Mice
(50)
Preclinical Testing
(50)
Xenograft Model Antitumor Assays
(45)
Female
(39)
Cell Line, Tumor
(33)
Mice, Scid
(32)
Mice, Inbred Balb C
(27)
Child
(23)
Antineoplastic Agents - Pharmacology
(21)
Neoplasms, Experimental - Drug Therapy
(19)
Cell Proliferation - Drug Effects
(17)
Drug Evaluation, Preclinical
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library
(81)
Journals@Ovid Ovid Full Text
(72)
MEDLINE
(58)
EZB Electronic Journals Library
(11)
IngentaConnect Journals
(6)
Psychology & Behavioral Sciences Collection
(2)
JSTOR
(2)
Publisher or Other Site
(2)
Oxford journals
(1)

4 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sheathless capillary electrophoresis-mass spectrometry for anionic metabolic profiling

Sheathless capillary electrophoresis-mass spectrometry for anionic metabolic profiling: Liquid Phase Separations

Wanted? Standard operating procedures for journals

Research ethics – a brief historical review to 1965

Fraud and the editor

Interaction of ultraviolet light, chemicals and cultured mammalian cells: photobiological reactions of halogenated antiseptics, drugs and dyes

Fraud and Misconduct in Medical Research (Book Review)

Stochastic representations of model uncertainties at ECMWF: state of the art and future vision

In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts

Improved recovery of SARS-CoV-2 from wastewater through application of RNA and DNA stabilising agents

Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

The pediatric preclinical testing program: Description of models and early testing results

In vivo activity of the dual SYK/FLT3 inhibitor TAK‐659 against pediatric acute lymphoblastic leukemia xenografts

Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program

Initiation of convection over the Black Forest mountains during COPS IOP15a

Initial testing of VS‐4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

Understanding species distribution in dynamic populations: a new approach using spatio‐temporal point process models

Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program

Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

Aktive Filter

Suchergebnisse filtern